Budesonide/Formoterol Inhalation Therapy Improves Lung Function in ... Medscape (subscription) - 8 hours ago In the 6-month SHINE study, 1704 patients aged 40 years and older with moderate to very severe COPD were randomized to 1 of 6 treatment groups: 2 ... |
Medimix International’s Panels Provide Unique Insights into ... PharmiWeb.com (press release), UK - 10 hours ago Most recently it finished a study in “pharmerging” markets among patients and prescribers of COPD, as part of a larger study incorporating Australia, ... |
GSK Reports Encouraging Results From Bone Density Study in COPD ... RedOrbit, TX - 15 hours ago ... in 186 patients (females and males 43 to 87 years of age) with chronic obstructive pulmonary disease (COPD) in a three-year double-blind study. ... |
Visit the new MedlinePlus Health Topic page on concussion.
A concussion is a type of brain injury. It's the most minor form. Technically, a concussion is a short loss of normal brain function in response to a head injury, but people use the term to describe any minor injury to the head or brain. Concussions are a common type of sports injury...
Visit It's a Noisy Planet from the National Institute on Deafness and Other Communication Disorders to learn how to protect your child from noise-induced hearing loss. Also, visit the MedlinePlus health topic pages on noise and hearing problems in children.
CHEST: Two COPD Drugs Show Similar Effects on Bone Mineral Density MedPage Today, NJ - 12 hours ago Explain to interested patients that this study found that two common COPD medications -- one containing a corticosteroid -- were associated with similar ... CHEST: Asthma Medications May Lend Small Benefit to COPD Patients MedPage Today CHEST: Arformoterol Passes Six-Month Safety Test in COPD MedPage Today CHEST: Specialists Disagree with Primary Care Doctors on Beta ... MedPage Today all 4 news articles |
NIH Awards Approximately $3M Grant for Research Involving ... MarketWatch - 14 hours ago The PulmoSmartChip, which will include the lowest number of genes that distinguish all phenotypes of IPF and COPD, will be used to identify and validate ... |
CHEST: Asthma Medications May Lend Small Benefit to COPD Patients MedPage Today, NJ - Oct 30, 2008 In an analysis of four placebo-controlled trials of COPD patients, treatment with the leukotriene antagonists zafirlukast (Accolate) and montelukast ... CHEST: Two COPD Drugs Show Similar Effects on Bone Mineral Density MedPage Today CHEST: Specialists Disagree with Primary Care Doctors on Beta ... MedPage Today all 4 news articles |
AstraZeneca Pushing Asthma Treatment Symbicort for COPD Network Médica, Argentina - 17 hours ago AstraZeneca filed an application with the US Food and Drug Administration (FDA) in April for approval to sell Symbicort as a treatment for COPD, in addition ... |
Treating COPD With Inhaled Steroids: Killing Two Birds With One Stone? Medical News Today (press release), UK - 21 hours ago Chronic obstructive pulmonary disease (COPD) is one of the five leading causes of death worldwide. It is characterised by an inflammatory response to ... |